Montreal-based digital health and AI startup Hexoskin has secured $4.2 million to develop a new AI diagnostic solution, access growth, and support digital biomarkers research.
Co-founded in 2006 by Pierre-Alexandre Fournier and Jean-Francois Roy, the company develops smart health monitoring wearables designed to capture personal health metrics.
Hexoskin’s smart garments can track physical activity, sleep, and cardiorespiratory activity, with the data transmitted directly to users’ smartphones, enabling them to monitor their health.
The latest funding round was backed by BDC Capital (Canada), AQC Capital and Anges Quebec (Canada), Deep Divers Ltd (UK), and Ballas Invest (Europe), alongside 19 angel investors from the US and Canada.
With the rapid technological advancements witnessed across every sector of the global economy, AI-powered systems are poised to transform healthcare diagnostics and improve patient outcomes.
Digital platforms can be leveraged to develop a wide range of medical diagnostic tests and other powerful digital solutions to address the unmet healthcare needs of populations in underserved areas.
These AI-powered health monitoring systems could help detect respiratory, cardiac, and other rare diseases early.
Hexoskin Smart Wearables
The company’s wearable sensing health monitoring products, Hexoskin and Astroskinare, are used in many fields, including defense, clinical research, and aerospace. The products’ customers include NASA, CSA, DOD, Boston Children’s Hospital, Yale Health, and hundreds of research teams worldwide.
Since their development, Hexoskin smart shirts have also been part of pharmaceutical clinical trials, and its technology has been used in the International Space Station clinical trials since 2019.